Literature DB >> 30279274

Translational Methods in Nephrology: Individual Treatment Effect Modeling.

F Perry Wilson1, Chirag R Parikh2,3.   

Abstract

Keywords:  machine-learning; marketing; outcomes; personalized medicine; randomized controlled trials; uplift

Mesh：

Year:  2018        PMID： 30279274      PMCID： PMC6218865          DOI： 10.1681/ASN.2018060629

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN： 1046-6673            Impact factor:   10.121


× No keyword cloud information.
  6 in total

1.  Identification of Patients Expected to Benefit from Electronic Alerts for Acute Kidney Injury.

Authors:  Aditya Biswas; Chirag R Parikh; Harold I Feldman; Amit X Garg; Stephen Latham; Haiqun Lin; Paul M Palevsky; Ugochukwu Ugwuowo; F Perry Wilson
Journal:  Clin J Am Soc Nephrol       Date:  2018-03-29       Impact factor: 8.237

2.  The number needed to treat: a clinically useful measure of treatment effect.

Authors:  R J Cook; D L Sackett
Journal:  BMJ       Date:  1995-02-18

3.  Meta-analysis: antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation.

Authors:  Robert G Hart; Lesly A Pearce; Maria I Aguilar
Journal:  Ann Intern Med       Date:  2007-06-19       Impact factor: 25.391

4.  Risk and treatment effect heterogeneity: re-analysis of individual participant data from 32 large clinical trials.

Authors:  David M Kent; Jason Nelson; Issa J Dahabreh; Peter M Rothwell; Douglas G Altman; Rodney A Hayward
Journal:  Int J Epidemiol       Date:  2016-12-01       Impact factor: 7.196

5.  A Randomized Trial of Intensive versus Standard Blood-Pressure Control.

Authors:  Jackson T Wright; Jeff D Williamson; Paul K Whelton; Joni K Snyder; Kaycee M Sink; Michael V Rocco; David M Reboussin; Mahboob Rahman; Suzanne Oparil; Cora E Lewis; Paul L Kimmel; Karen C Johnson; David C Goff; Lawrence J Fine; Jeffrey A Cutler; William C Cushman; Alfred K Cheung; Walter T Ambrosius
Journal:  N Engl J Med       Date:  2015-11-09       Impact factor: 91.245

6.  Relevance of breast cancer hormone receptors and other factors to the efficacy of adjuvant tamoxifen: patient-level meta-analysis of randomised trials.

Authors:  C Davies; J Godwin; R Gray; M Clarke; D Cutter; S Darby; P McGale; H C Pan; C Taylor; Y C Wang; M Dowsett; J Ingle; R Peto
Journal:  Lancet       Date:  2011-07-28       Impact factor: 79.321
  6 in total
  1 in total

1.  Bucindolol for the Maintenance of Sinus Rhythm in a Genotype-Defined HF Population: The GENETIC-AF Trial.

Authors:  Jonathan P Piccini; William T Abraham; Christopher Dufton; Ian A Carroll; Jeff S Healey; Dirk J van Veldhuisen; William H Sauer; Inder S Anand; Michel White; Stephen B Wilton; Ryan Aleong; Michiel Rienstra; Steven K Krueger; Felix Ayala-Paredes; Yaariv Khaykin; Bela Merkely; Vladimir Miloradović; Jerzy K Wranicz; Leonard Ilkhanoff; Paul D Ziegler; Gordon Davis; Laura L Emery; Debra Marshall; David P Kao; Michael R Bristow; Stuart J Connolly
Journal:  JACC Heart Fail       Date:  2019-04-29       Impact factor: 12.035
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.